drugset / Trial / NCT00002057
Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC
Completed
Bristol-Myers Squibb
Treatment
Summary
To determine a safe, effective, and convenient dosing schedule for nystatin pastilles in the prevention of oral candidiasis in patients with AIDS or AIDS related complex (ARC) (group III or IV, CDC classification).
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nystatin | Unknown | — | — |